t(8;13)-positive bilineal lymphomas: Report of 6 cases

American Journal of Surgical Pathology

Volumn 32, Issue 1, 2008, Pages 14-20

  Vega, Francisco ^a   Jeffrey Medeiros, L ^a   Davuluri, Rajayogesh ^a   Cromwell, Candy C ^a   Alkan, Serhan ^a   Abruzzo, Lynne V ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

8p11 myeloproliferative syndrome; Bilineal; Malignant lymphoma; t(8; 13)

Indexed keywords

CD3 ANTIGEN;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; BREAST CANCER; CELL LINEAGE; CELL ULTRASTRUCTURE; CHILD; CHROMOSOME 8P; CHROMOSOME TRANSLOCATION 8; CLINICAL ARTICLE; CYTOPLASM; DIFFERENTIAL DIAGNOSIS; EOSINOPHIL; EOSINOPHILIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPH FOLLICLE; LYMPH NODE BIOPSY; LYMPHADENOPATHY; LYMPHOMA; MALE; MYELOPROLIFERATIVE DISORDER; NEUTROPHILIA; T LYMPHOCYTE; VASCULAR ENDOTHELIUM;

ADOLESCENT; ADULT; ANTIGENS, CD; CELL LINEAGE; CHILD; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; GRANULOCYTE PRECURSOR CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPHOCYTES; LYMPHOMA; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSLOCATION, GENETIC;

EID: 37549036314     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31814b226e     Document Type: Article

References (56)

1. Abruzzo LV, Jaffe ES, Cotelingam JD, et al. T-cell lymphoblastic lymphoma with eosinophilia associated with subsequent myeloid malignancy. Am J Surg Pathol. 1992;16:236-245.
2. Aguiar RC, Chase A, Coulthard S, et al. Abnormalities of chromosome band 8p11 in leukemia: two clinical syndromes can be distinguished on the basis of MOZ involvement. Blood. 1997;90:3130-3135.
3. Akashi K, Mizuno S, Harada M, et al. T lymphoid/myeloid bilineal crisis in chronic myelogenous leukemia. Exp Hematol. 1993;21:743-748.
4. Anderson MK, Hernandez-Hoyos G, Diamond RA, et al. Precise developmental regulation of Ets family transcription factors during specification and commitment to the T cell lineage. Development. 1999;126:3131-3148.
5. Anderson MK, Weiss AH, Hernandez-Hoyos G, et al. Constitutive expression of PU.1 in fetal hematopoietic progenitors blocks T cell development at the pro-T cell stage. Immunity. 2002;16:285-296.
6. Behringer D, Schaefer HE, Kunzmann R, et al. Translocation t(8;13) in a patient with T cell lymphoma and features of a myeloproliferative syndrome. Leukemia. 1995;9:988-992.
7. Belloni E, Trubia M, Gasparini P, et al. 8p11 myeloproliferative syndrome with a novel t(7;8) translocation leading to fusion of the FGFR1 and TIF1 genes. Genes Chromosomes Cancer. 2005;42:320-325.
8. Bene MC, Castoldi G, Knapp W, et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia. 1995;9:1783-1786.
9. Brunning RD, Matutes E, Borowitz M, et al. Acute leukemias of ambiguous lineage. In: Jaffe ES, Harris NL, Stein H, et al, eds. Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2001:106-107.
10. Casasnovas RO, Campos L, Mugneret F, et al. Immunophenotypic patterns and cytogenetic anomalies in acute non-lymphoblastic leukemia subtypes: a prospective study of 432 patients. Leukemia. 1998;12:34-43.
11. Chaffanet M, Popovici C, Leroux D, et al. t(6;8), t(8;9) and t(8;13) translocations associated with stem cell myeloproliferative disorders have close or identical breakpoints in chromosome region 8p11-12. Oncogene. 1998;16:945-949.
12. Chen HM, Zhang P, Voso MT, et al. Neutrophils and monocytes express high levels of PU.1 (Spi-1) but not Spi-B. Blood. 1995;85:2918-2928.
13. Chernova O, Still I, Kalaycio M, et al. Characterization of the breakpoints in a t(8;13)(p11;q12) translocation from a patient with myeloproliferative disease using fluorescence in situ hybridization. Genes Chromosomes Cancer. 1998;21:160-165.
14. Demiroglu A, Steer EJ, Heath C, et al. The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins. Blood. 2001;98:3778-3783.
15. Fagan K, Hyde S, Harrison P. Translocation (8;13) and T-cell lymphoma. A case report. Cancer Genet Cytogenet. 1993;65:71-73.
16. Friedhoff F, Rajendra B, Moody R, et al. Novel reciprocal translocation between chromosomes 8 and 9 found in a patient with myeloproliferative disorder. Cancer Genet Cytogenet. 1983;9:391-394.
17. Grand EK, Grand FH, Chase AJ, et al. Identification of a novel gene, FGFR1OP2, fused to FGFR1 in 8p11 myeloproliferative syndrome. Genes Chromosomes Cancer. 2004;40:78-83.
18. Guasch G, Mack GJ, Popovici C, et al. FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33). Blood. 2000;95:1788-1796.
19. Guasch G, Popovici C, Mugneret F, et al. Endogenous retroviral sequence is fused to FGFR1 kinase in the 8p12 stem-cell myeloproliferative disorder with t(8;19)(p12;q13.3). Blood. 2003;101:286-288.
20. Inhorn RC, Aster JC, Roach SA, et al. A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity. Blood. 1995;85:1881-1887.
21. JabbarAl-Obaidi M, Rymes N, White P, et al. A fourth case of 8p11 myeloproliferative disorder transforming to B-lineage acute lymphoblastic leukaemia. A case report. Acta Haematol. 2002;107:98-100.
22. Jotterand Bellomo M, Muhlematter D, Wicht M, et al. t(8;9)(p11;q32) in atypical chronic myeloid leukaemia: a new cytogenetic-clinicopathologic association? Br J Haematol. 1992;81:307-308.
23. King AG, Kondo M, Scherer DC, et al. Lineage infidelity in myeloid cells with TCR gene rearrangement: a latent developmental potential of proT cells revealed by ectopic cytokine receptor signaling. Proc Natl Acad Sci U S A. 2002;99:4508-4513.
24. Leslie J, Barker T, Glancy M, et al. t(8;13) (p11;q12) translocation in a myeloproliferative disorder associated with a T-cell non-Hodgkin lymphoma. Br J Haematol. 1994;86:876-878.
25. Lewis JP, Jenks H, Lazerson J. Philadelphia chromosome-negative chronic myelogenous leukemia in a child with t(8;9)(p11 or 12;q34). Am J Pediatr Hematol Oncol. 1983;5:265-269.
26. Macdonald D, Sheerin SM, Cross NC, et al. An atypical myeloproliferative disorder with t(8;13) (p11;q12): a third case. Br J Haematol. 1994;86:879-880.
27. Martinez-Climent JA, Vizcarra E, Benet I, et al. Cytogenetic response induced by interferon alpha in the myeloproliferative disorder with eosinophilia, T cell lymphoma and the chromosomal translocation t(8;13)(p11;q12). Leukemia. 1998;12:999-1000.
28. Matsumoto K, Morita K, Takada S, et al. A chronic myelogenous leukemia-like myeloproliferative disorder accompanied by T-cell lymphoblastic lymphoma with chromosome translocation t(8;13) (p11;q12): a Japanese case. Int J Hematol. 1999;70:278-282.
29. Matutes E, Morilla R, Farahat N, et al. Definition of acute biphenotypic leukemia. Haematologica. 1997;82:64-66.
30. Michaux L, Mecucci C, Pereira Velloso ER, et al. About the t(8;13)(p11;q12) clinico-pathologic entity. Blood. 1996;87:1658-1659.
31. Monma F, Nishii K, Ezuki S, et al. Molecular and phenotypic analysis of Philadelphia chromosome-positive bilineage leukemia: possibility of a lineage switch from T-lymphoid leukemic progenitor to myeloid cells. Cancer Genet Cytogenet. 2006;164:118-121.
32. Nakayama H, Inamitsu T, Ohga S, et al. Chronic myelomonocytic leukaemia with t(8;9)(p11;q34) in childhood: an example of the 8p11 myeloproliferative disorder? Br J Haematol. 1996;92:692-695.
33. Nerlov C, Graf T. PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. Genes Dev. 1998;12:2403-2412.
34. Oscier DG, Gardiner A, Dyer M. t(8;9) in chronic myeloid leukaemia. Br J Haematol. 1993;83:176-177.
35. Popovici C, Adelaide J, Ollendorff V, et al. Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13). Proc Natl Acad Sci U S A. 1998;95:5712-5717.
36. Rao PH, Cesarman G, Coleman M, et al. Cytogenetic evidence for extramedullary blast crisis with t(8;13)(q11;p11) in chronic myelomonocytic leukemia. Acta Haematol. 1992;88:201-203.
37. Reiter A, Sohal J, Kulkarni S, et al. Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndrome. Blood. 1998;92:1735-1742.
38. Roy S, Szer J, Campbell LJ, et al. Sequential transformation of t(8;13)-related disease: a case report. Acta Haematol. 2002;107:95-97.
39. Smedley D, Demiroglu A, Abdul-Rauf M, et al. ANF198-FGFR1 transforms Ba/F3 cells to growth factor independence and results in high level tyrosine phosphorylation of STATS 1 and 5. Neoplasia. 1999;1:349-355.
40. Sohal J, Chase A, Mould S, et al. Identification of four new translocations involving FGFR1 in myeloid disorders. Genes Chromosomes Cancer. 2001;32:155-163.
41. Somers GR, Slater H, Rockman S, et al. Coexistent T-cell lymphoblastic lymphoma and an atypical myeloproliferative disorder associated with t(8;13)(p21;q14). Pediatr Pathol Lab Med. 1997;17:141-158.
42. Still IH, Chernova O, Hurd D, et al. Molecular characterization of the t(8;13)(p11;q12) translocation associated with an atypical myeloproliferative disorder: evidence for three discrete loci involved in myeloid leukemias on 8p11. Blood. 1997;90:3136-3141.
43. Suzan F, Guasch G, Terre C, et al. Long-term complete haematological and molecular remission after allogeneic bone marrow transplantation in a patient with a stem cell myeloproliferative disorder associated with t(8;13)(p12;q12). Br J Haematol. 2003;121:312-314.
44. Tassies D, Cervantes F, Feliu E, et al. T-cell lymphoblastic lymphoma with blood eosinophilia and associated myeloid malignancy. Am J Surg Pathol. 1993;17:92-93.
45. van den Berg H, Kroes W, van der Schoot CE, et al. A young child with acquired t(8;9)(p11;q34): additional proof that 8p11 is involved in mixed myeloid/T lymphoid malignancies. Leukemia. 1996;10:1252-1253.
46. Vangala RK, Heiss-Neumann MS, Rangatia JS, et al. The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia. Blood. 2003;101:270-277.
47. Vannier JP, Bizet M, Bastard C, et al. Simultaneous occurrence of a T-cell lymphoma and a chronic myelogenous leukemia with an unusual karyotype. Leuk Res. 1984;8:647-657.
48. Vega F, Medeiros LJ, Lang WH, et al. The stromal composition of malignant lymphoid aggregates in bone marrow: variations in architecture and phenotype in different B-cell tumours. Br J Haematol. 2002;117:569-576.
49. Vizmanos JL, Hernandez R, Vidal MJ, et al. Clinical variability of patients with the t(6;8)(q27;p12) and FGFR1OP-FGFR1 fusion: two further cases. Hematol J. 2004;5:534-537.
50. Walz C, Chase A, Schoch C, et al. The t(8;17)(p11;q23) in the 8p11 myeloproliferative syndrome fuses MYO18A to FGFR1. Leukemia. 2005;19:1005-1009.
51. Weerkamp F, Baert MR, Brugman MH, et al. Human thymus contains multipotent progenitors with T/B lymphoid, myeloid, and erythroid lineage potential. Blood. 2006;107:3131-3137.
52. Wong WS, Cheng KC, Lau KM, et al. Clonal evolution of 8p11 stem cell syndrome in a 14-year-old Chinese boy: A review of literature of t(8;13) associated myeloproliferative diseases. Leuk Res. 2006. [Epub ahead of print].
53. Xiao S, Nalabolu SR, Aster JC, et al. FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome. Nat Genet. 1998;18:84-87.
54. Yamamoto K, Kawano H, Nishikawa S, et al. A biphenotypic transformation of 8p11 myeloproliferative syndrome with CEP1/FGFR1 fusion gene. Eur J Haematol. 2006;77:349-354.
55. Yashima-Abo A, Satoh T, Abo T, et al. Distinguishing between proliferating nodal lymphoid blasts in chronic myelogenous leukemia and non-Hodgkin lymphoma: report of three cases and detection of a bcr/abl fusion signal by single-cell analysis. Pathol Int. 2005;55:273-279.
56. Zheng R, Friedman AD, Levis M, et al. Internal tandem duplication mutation of FLT3 blocks myeloid differentiation through suppression of C/EBPalpha expression. Blood. 2004;103:1883-1890.